# Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DM

> **NCT00577590** · NA · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 78 (actual)

## Conditions studied

- Diabetes Mellitus, Type II

## Interventions

- **DRUG:** Metformin
- **DRUG:** Rosiglitazone
- **DRUG:** Lovaza

## Key facts

- **NCT ID:** NCT00577590
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** 2012-08
- **Final completion:** 2012-09
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2018-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00577590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00577590, "Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DM". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00577590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*